Search for: "MYLAN LABORATORIES LTD. "
Results 61 - 80
of 104
Sorted by Relevance
|
Sort by Date
27 May 2011, 8:56 am
Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
17 Apr 2012, 5:55 pm
In a unanimous decision delivered by Justice Elena Kagan (along with a concurring opinion from Justice Sonia Sotomayor) on April 17, 2012, the Court held in Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
12 Oct 2011, 12:33 pm
In addition, the Court denied a petition for certiorari brought by generic drug manufacturer Mylan Laboratories, Inc. [read post]
21 Mar 2012, 11:32 am
The ruling, which was a victory for Mylan Inc.'s UDL Laboratories, Actavis Inc., and Teva Pharmaceutical Industries Ltd. by a 5-4 vote, overturned appeals court decisions that allowed for such complaints. [read post]
9 Sep 2009, 7:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: CAFC debates whether claim term ‘animal’ includes humans: Martek Biosciences Corp v Nutrinova, Inc (Gray on Claims) (Patently-O) (Patently-O) (IP Watchdog) General USPTO-Pfizer workshop on IP & innovation in Mumbai (Intellectual Property Watch) Australia: Full Federal Court unanimously confirms that… [read post]
21 Oct 2014, 12:00 am
In Novartis AG v Generics (UK) Limited (t/a Mylan) [2012] EWCA Civ1623, discussed by the IPKat (see here) the Court of Appeal had to review the decision of Floyd J (here) in assessing inventive step where the compound went through several steps during research and development. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
22 Dec 2010, 3:01 am
Watson Laboratories, Inc. [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
2 Jul 2017, 12:52 am
Fussell & Sons Ltd. (1908), 25 R.P.C. 631(C.A.), at p. 650). [read post]
1 Jul 2017, 9:39 am
Fussell & Sons Ltd. (1908), 25 R.P.C. 631(C.A.), at p. 650). [read post]
20 Sep 2021, 3:31 pm
Mylan Laboratories Ltd. [read post]
1 Feb 2016, 10:43 am
Hoffman-La Roche Ltd., 580 F.3d 1340,1369 (Fed. [read post]
27 Sep 2009, 5:13 pm
Takeda Chemical Industries, Ltd., et al. ; Alphapharm Pty., Ltd., et al. v. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
28 Mar 2014, 5:33 pm
.; Teva Pharmaceutical Industries, Ltd.; Lupin, Ltd.; Lupin Pharmaceuticals, Inc.; Actavis, Inc.; Actavis Elizabeth, LLC; Cobalt Laboratories, Inc.; Cobalt Pharmaceuticals, Inc.; Sun Pharma Global, Inc; Sun Pharmaceutical Industries, Ltd.; Sun Pharmaceutical Industries, Inc.; Wockhardt Ltd.; and Mylan Pharmaceuticals, Inc. [read post]
5 Mar 2015, 5:52 am
., Ltd. v. [read post]
9 Dec 2009, 3:59 pm
Ltd. et al. v. [read post]
24 Mar 2011, 12:53 pm
Rodriguez Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
